TY - JOUR TI - Ion permeation pathway within the internal pore of P2X receptor channels AU - Tam, Stephanie W AU - Huffer, Kate AU - Li, Mufeng AU - Swartz, Kenton J A2 - Pless, Stephan A A2 - Aldrich, Richard W A2 - Grutter, Thomas A2 - Qiu, Zhaozhu A2 - Miller, Alexandria N VL - 12 PY - 2023 DA - 2023/03/20 SP - e84796 C1 - eLife 2023;12:e84796 DO - 10.7554/eLife.84796 UR - https://doi.org/10.7554/eLife.84796 AB - P2X receptor channels are trimeric ATP-activated ion channels expressed in neuronal and non-neuronal cells that are attractive therapeutic targets for human disorders. Seven subtypes of P2X receptor channels have been identified in mammals that can form both homomeric and heteromeric channels. P2X1–4 and P2X7 receptor channels are cation-selective, whereas P2X5 has been reported to have both cation and anion permeability. P2X receptor channel structures reveal that each subunit is comprised of two transmembrane helices, with both N-and C-termini on the intracellular side of the membrane and a large extracellular domain that contains the ATP binding sites at subunit interfaces. Recent structures of ATP-bound P2X receptors with the activation gate open reveal the unanticipated presence of a cytoplasmic cap over the central ion permeation pathway, leaving lateral fenestrations that may be largely buried within the membrane as potential pathways for ions to permeate the intracellular end of the pore. In the present study, we identify a critical residue within the intracellular lateral fenestrations that is readily accessible to thiol-reactive compounds from both sides of the membrane and where substitutions influence the relative permeability of the channel to cations and anions. Taken together, our results demonstrate that ions can enter or exit the internal pore through lateral fenestrations that play a critical role in determining the ion selectivity of P2X receptor channels. KW - ATP KW - purinergic KW - ion permeation KW - ion selectivity KW - P2X JF - eLife SN - 2050-084X PB - eLife Sciences Publications, Ltd ER -